Cargando…
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Approximately 5% of individuals infected with hepatitis B virus (HBV) are coinfected with hepatitis D virus (HDV). Chronic HBV/HDV coinfection is associated with an unfavourable outcome, with many patients developing liver cirrhosis, liver failure and eventually hepatocellular carcinoma within 5–10...
Autores principales: | Urban, Stephan, Neumann-Haefelin, Christoph, Lampertico, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355886/ https://www.ncbi.nlm.nih.gov/pubmed/34103404 http://dx.doi.org/10.1136/gutjnl-2020-323888 |
Ejemplares similares
-
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
por: Luxenburger, Hendrik, et al.
Publicado: (2023) -
Intestinal microbiota in functional bowel disorders: a Rome foundation report
por: Simrén, Magnus, et al.
Publicado: (2013) -
Symptomatic reflux disease: the present, the past and the future
por: Boeckxstaens, Guy, et al.
Publicado: (2014) -
Expert opinions and scientific evidence for colonoscopy key performance indicators
por: Rees, Colin J, et al.
Publicado: (2016) -
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
por: Lawler, Mark, et al.
Publicado: (2018)